FDA-approved drug effectively treats rare chronic immune disorders
A drug approved to treat a severe form of asthma dramatically improved the health of people with rare chronic immune disorders called hypereosinophilic syndromes (HES) in whom other treatments were ineffective or intolerable. ...
Apr 3, 2019
0
942